Narmada Gelatines Limited has scheduled a board meeting on February 12, 2026, to review and approve its financial performance for the third quarter of fiscal year 2026. The company formally notified the Bombay Stock Exchange on February 04, 2026, regarding this important corporate development.

Board Meeting Details

The meeting will be held at Jabalpur and will focus on several key agenda items related to the company's financial disclosure obligations.

Regulatory Compliance and Trading Window

In accordance with SEBI regulations, Narmada Gelatines Limited has implemented a trading window closure to prevent insider trading. The company has established specific timelines for this restriction period.

Corporate Governance Framework

The announcement demonstrates the company's adherence to regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting notification was signed by Company Secretary Mahima Patkar, reflecting the company's commitment to proper corporate governance procedures.

The financial results to be considered will cover both quarterly performance for the three months ended December 31, 2025, and cumulative performance for the nine-month period ending on the same date. The board will also review limited review reports from the company's auditors as part of the approval process.

Market Impact and Investor Information

The scheduled board meeting represents a routine but significant corporate event for stakeholders tracking Narmada Gelatines Limited's financial performance. The company operates under BSE Security Code 526739 and maintains its registered office at Jabalpur, Madhya Pradesh. Following the declaration of results, normal trading activities will resume for all restricted parties after the 48-hour cooling period concludes on February 14, 2026.

Narmada Gelatines Limited, a leading manufacturer of ossein and gelatine, has announced its unaudited financial results for the first quarter, showcasing robust growth in both revenue and profitability.

Financial Highlights

• Revenue Growth: The company reported standalone revenue from operations of Rs. 4,577.00 lakhs for the quarter, marking a 5.9% increase from Rs. 4,322.00 lakhs in the same quarter of the previous year.

• Profit Surge: Standalone profit for the period rose significantly to Rs. 498.00 lakhs, up 24.5% from Rs. 400.00 lakhs year-over-year.

• Consolidated Performance: On a consolidated basis, the company's profit reached Rs. 598.00 lakhs for the quarter, which includes a proportionate share of profit from its associate, India Gelatine and Chemicals Limited, amounting to Rs. 100.00 lakhs.

• Earnings Per Share: The basic and diluted earnings per share stood at Rs. 8.23 for standalone results, reflecting the company's strong financial performance.

Key Financial Metrics

Operational Performance

The company's operational efficiency is evident from its ability to manage costs effectively while growing its revenue. The cost of materials consumed decreased slightly to Rs. 2,596.00 lakhs compared to Rs. 2,674.00 lakhs in the same quarter of the previous year, despite the increase in revenue.

Corporate Governance Update

In a move to ensure transparency and maintain high standards of corporate governance, the Board of Directors has approved a revision in the remuneration of the company's statutory auditors, Lodha & Co. LLP. The new remuneration is set at Rs. 7.50 lakhs per annum, subject to shareholder approval at the upcoming Annual General Meeting.

Management Commentary

While specific management comments were not provided in the available data, the financial results reflect the company's strong market position and operational efficiency in the ossein and gelatine manufacturing sector.

Looking Ahead

Narmada Gelatines Limited's robust start to the quarter positions it well for continued growth. The company's ability to increase profitability at a higher rate than revenue growth suggests improving operational efficiencies and potentially favorable market conditions.

Investors and stakeholders will likely keep a close eye on how the company maintains this momentum in the coming quarters, especially in light of any potential market challenges or opportunities in the ossein and gelatine industry.

Note: The financial results discussed in this article are subject to limited review by the company's statutory auditors as per regulatory requirements.